Parathyroid hormone: anabolic and catabolic actions on the skeleton

BC Silva, JP Bilezikian - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Parathyroid hormone has dual anabolic and catabolic actions on the
skeleton.•The OPG–RANKL–RANK pathway is the main mediator of the catabolic actions of …

WNT signaling in bone development and homeostasis

Z Zhong, NJ Ethen, BO Williams - Wiley Interdisciplinary …, 2014 - Wiley Online Library
The balance between bone formation and bone resorption controls postnatal bone
homeostasis. Research over the last decade has provided a vast amount of evidence that …

Directed evolution identifies high-affinity cystine-knot peptide agonists and antagonists of Wnt/β-catenin signaling

S Hansen, Y Zhang, S Hwang… - Proceedings of the …, 2022 - National Acad Sciences
Developing peptide-based tools to fine-tune growth signaling pathways, in particular
molecules with exquisite selectivity and high affinities, opens up opportunities for cellular …

Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and-independent Wnt pathways

W Bouaziz, T Funck-Brentano, H Lin, C Marty… - Arthritis research & …, 2015 - Springer
Abstract Introduction Sclerostin is a Wnt inhibitor produced by osteocytes that regulates
bone formation. Because bone tissue contributes to the development of osteoarthritis (OA) …

Mechanical load increases in bone formation via a sclerostin‐independent pathway

A Morse, MM McDonald, NH Kelly… - Journal of Bone and …, 2014 - academic.oup.com
Sclerostin, encoded by the Sost gene, is an important negative regulator of bone formation
that has been proposed to have a key role in regulating the response to mechanical loading …

Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels

MK Chang, I Kramer, T Huber… - Proceedings of the …, 2014 - National Acad Sciences
We identified previously in vitro LRP4 (low-density lipoprotein receptor-related protein 4) as
a facilitator of the WNT (Wingless-type) antagonist sclerostin and found mutations disrupting …

Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand

J Luther, TA Yorgan, T Rolvien, L Ulsamer… - Science translational …, 2018 - science.org
WNT1 mutations in humans are associated with a new form of osteogenesis imperfecta and
with early-onset osteoporosis, suggesting a key role of WNT1 in bone mass regulation …

Osteocytes regulate bone anabolic response to mechanical loading in male mice via activation of integrin α5

D Zhao, R Hua, MA Riquelme, H Cheng, T Guda… - Bone Research, 2022 - nature.com
Physical mechanical stimulation can maintain and even increase bone mass. Here, we
report an important role of osteocytic integrin α5 in regulating the anabolic response of bone …

Fat and bone interactions

S Bermeo, K Gunaratnam, G Duque - Current osteoporosis reports, 2014 - Springer
Fat and bone have a complicated relationship. Although obesity has been associated with
low fracture risk, there is increasing evidence that some of the factors that are released by …

Sclerostin antibody therapy for the treatment of osteoporosis: clinical prospects and challenges

C MacNabb, D Patton, JS Hayes - Journal of osteoporosis, 2016 - Wiley Online Library
It is estimated that over 200 million adults worldwide have osteoporosis, a disease that has
increasing socioeconomic impact reflected by unsustainable costs associated with disability …